When these elements are addressed in the correct order, GLP-1 therapy becomes part of a structured metabolic strategy rather than an isolated intervention
The pathway-overlap problem Complementarity arguments assume the mechanisms are independent
Verzola D, Picciotto D, Saio M, Aimasso F, Bruzzone F, Sukkar SG, et al
10.1016/S0140-6736(18)32261-X 47
GLP-1 drugs from Novo Nordisk and Eli Lilly and Company are sold under the brand names Ozempic and Mounjaro to treat type 2 diabetes, and under the names Wegovy and Zepbound to treat obesity
The synthesis of proteins and tissues, as well as the generation of red blood cells, are all dependent on adequate levels of vitamin B12